Keywords: Kidney, Kidney, Multi-parameter magnetic resonance imaging; Clear cell likelihood score; Clear cell renal cell carcinoma; Pseudocapsule
Motivation: Clear cell likelihood score version 2.0 (ccLS v2.0) is not yet able to predict malignancy in small renal masses (SRMs). Pseudocapsule may provide added value with ccLS v2.0
Goal(s): To develop a modified clear cell likelihood score based on pseudocapsule (m-ccLS) for predicting malignancy in SRMs
Approach: Receiver operating characteristic curve (ROC), net reclassification index (NRI), and integrated discrimination improvement (IDI) were used to compare diagnostic value of m-ccLS and ccLS v2.0
Results: Area under curve (AUC), NRI and IDI of m-ccLS were superior to those of ccLS v2.0 for the diagnosis of malignancy. The likelihood of malignancy increased with higher m-ccLS scores
Impact: M-ccLS achieved predict malignancy of small renal masses (SRMs). M-ccLS may be a valuable tool for expanding the clinical application of this scoring system and contributing to its further promotion and dissemination
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords